AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2022

May 6, 2022

31071_dirs_2022-05-05_659a6e87-11a9-4ea1-a96c-fc3df215c935.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2022-05-02

Reporting Person: Vakiener Victoria (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17181	Direct

Footnotes

F1: Includes a total of 17,181 shares underlying restricted stock units, which will vest over three years.